Oragenics Advances Towards Identification of Lead Antibiotic Clinical Candidate

[Business Wire] – Oragenics, Inc. announced today that through its Exclusive Channel Collaboration with Intrexon Corporation , a leader in synthetic biology, it has produced and analyzed a large number of new potential analogs generated from its Mutacin more

View todays social media effects on OGEN

View the latest stocks trending across Twitter. Click to view dashboard

See who Oragenics is hiring next, click here to view